Risks, Benefits, and the Optimal Time to Resume Deep Vein Thrombosis Prophylaxis in Patients with Intracranial Hemorrhage

Introduction It is common to start all patients on chemical prophylaxis for deep vein thrombosis (DVT) in order to decrease the risk of venous thromboembolism (VTE) and the associated adverse effects, including the potential for fatal pulmonary embolism (PE). There is no consensus in the literature...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cureus
Asıl Yazarlar: Farr, Saman, Toor, Harjyot, Patchana, Tye, Podkovik, Stacey, Wiginton, James G, Sweiss, Raed, Wacker, Margaret Rose, Miulli, Dan E
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Cureus 2019
Konular:
Quality Improvement
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6827698/
https://ncbi.nlm.nih.gov/pubmed/31754562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.5827
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller